Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
Clinical trial NCT07453342 · RECRUITING
Trial details
- NCT number
- NCT07453342
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-01
- Primary completion
- 2033-12-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.